Appointed
Joseph Haniford
Director
TG ·
TREDEGAR CORP
the Board elected Joseph Haniford as a director of the Company, effective immediately.
Ready 8-Ks
22
Latest filing
May 27, 2026, 4:28 PM ET
Top materiality
0.85
Event mix
earnings ×8 · leadership ×7 · other_material ×2
Sentiment
7 pos · 3 neg · 12 neu
Latest earnings
reported 2026-Q1
Executive change
recent →
Recent 8-K filings for TG
Highest-materiality recent filing
Brazilian competition authority approves Tredegar's sale of Terphane to Oben Group; closing expected Nov 1
- Brazil's CADE approved a merger control agreement on Oct 16, 2024, allowing Tredegar to sell Terphane to Oben Group.
- Base consideration for Terphane is $116 million net cash-free and debt-free.
-
Tredegar directors Freeman and Tack resign after failing re-election; Haniford appointed
George C. Freeman, III and Carl E. Tack, III failed to win majority votes at 2026 annual meeting; resigned effective May 22, 2026.
-
Tredegar Q4 net income $14.5M vs $7.3M loss; Aluminum Extrusions EBITDA up 61% YoY
Q4 ongoing EPS $0.32 vs $0.06; full-year ongoing EPS $0.74 vs $0.50.
-
Tredegar announces CEO and CFO retirements, names internal successors effective Jan 1, 2026
CEO John Steitz to retire Dec 31, 2025; Arijit DasGupta elected President and CEO effective Jan 1, 2026.
-
Tredegar Q3 2025 net income $7.1M vs year-ago loss of $3.4M
Net income from continuing operations $7.1M ($0.20/diluted share) compared to $(3.4)M ($(0.10)/share) in Q3 2024.
-
Tredegar CFO D. Andrew Edwards to retire effective Dec 31, 2025
D. Andrew Edwards, CFO & EVP, to retire on December 31, 2025.
-
Tredegar Q2 net income drops 80% to $1.8M; Aluminum Extrusions EBITDA falls 28% on tariff headwinds
Net income from continuing ops $1.8M ($0.05/diluted) vs $9.2M ($0.27) in Q2 2024; ongoing EPS $0.05 vs $0.30.
-
Tredegar Q1 net income falls to $0.7M; Aluminum Extrusions EBITDA down 27% YoY
GAAP net income from continuing ops $0.7M ($0.02/sh) vs $2.6M ($0.08/sh) Q1 2024.
-
Tredegar narrows Q4 net loss to $7.3M; ongoing EPS $0.06; both segments show EBITDA growth
Q4 2024 net loss from continuing ops $(7.3)M ($(0.21)/diluted) vs $(34.1)M ($(1.00)) in Q4 2023.
-
Tredegar Q3 2024 break-even ongoing ops; completes Terphane sale for $78M enterprise value
Q3 2024 net income from ongoing ops $0.2M ($0.01/share) vs loss of $5.1M ($0.15) in Q3 2023.
-
Tredegar completes sale of Terphane to Oben Group for $116M; expects $85M net proceeds
Sale closed Nov 1, 2024; total cash-free, debt-free base consideration of $116 million.
-
Brazil's CADE approved a merger control agreement on Oct 16, 2024, allowing Tredegar to sell Terphane to Oben Group.
-
Tredegar swings to Q2 profit of $0.26/share vs loss of $0.56 YoY; segment EBITDA improves
Net income $8.8M ($0.26 diluted) vs loss $18.9M ($0.56) in Q2 2023.
-
Tredegar Updates on Brazilian Merger Review for Terphane Sale to Oben Group
SG-CADE issued a non-binding opinion on May 13, 2024 recommending rejection of the Terphane sale to Oben Group.
Executive changes
Departed
George C. Freeman, III
Director
TG ·
TREDEGAR CORP
each of Mr. Freeman and Mr. Tack tendered his respective resignation to the Nominating and Governance Committee
Departed
Carl E. Tack, III
Director
TG ·
TREDEGAR CORP
each of Mr. Freeman and Mr. Tack tendered his respective resignation to the Nominating and Governance Committee
Appointed
Christine R. Vlahcevic
Director
TG ·
TREDEGAR CORP
On January 9, 2025, the Board of Directors (the “Board”) of Tredegar Corporation (the “Company”) increased the size of the Board from six to seven and elected Christine R. Vlahcevic as director of the Company, in each case, effective immediately.
Earnings & guidance
Materiality & sentiment trend
Max materiality 0.85 · Median 0.60 · Most common event earnings